864 Identification of a novel allosteric oral Cbl-b inhibitor that augmented T cell response and enhanced NK cell killing in vitro and in vivo

• Fang Wang,
• Jun Kuai,
• Yingzhi Bi,
• Yilin Qi,
• Deborah Conrady,
• Rajiv Govindaraj,
• Graham Hone,
• R Aldrin Denny,
• Ken Carson,
• Geraldine Harriman

Affiliations

Fang Wang

Center for the Study of Itch and Sensory Disorders, Washington University School of Medicine in St Louis, St Louis, Missouri, USA

Jun Kuai

HoSpot Therapeutics, Boston, MA, USA

Yingzhi Bi

HoSpot Therapeutics, Boston, MA, USA

Yilin Qi

HoSpot Therapeutics, Boston, MA, USA

Deborah Conrady

HoSpot Therapeutics, Boston, MA, USA

Rajiv Govindaraj

HoSpot Therapeutics, Boston, MA, USA

Graham Hone

HoSpot Therapeutics, Boston, MA, USA

R Aldrin Denny

HoSpot Therapeutics, Boston, MA, USA

Ken Carson

HoSpot Therapeutics, Boston, MA, USA

Geraldine Harriman

HoSpot Therapeutics, Boston, MA, USA